This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
French Therapeutic Drug Monitoring (TDM) Market 2015: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $19,500. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and assist industry executives in developing effective business, new ...
June 2016 | $0 | View Details >>
- How will the future reimbursement changes affect individual market segments?- Will the industry consolidate, decentralize, or undergo a bimodal transformation?- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?- How will the future technological advances affect the major market segments?- ...
March 2017 | $0 | View Details >>
The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market ...
November 2015 | $2800 | View Details >>
2015-2019 European Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers-Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review
This new 273-page report from VPGMarketResearch.com provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the follow assays:C3C4Free Light ChainsHaptoglobinIgAIgE Specific IgE ...
July 2015 | $4200 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research